Amy Sims

19.1k citations
77 papers · 7.5k · 5 hit papers · h-index 36

Impact in

    • SARS-CoV-2 and COVID-19 Research
    • COVID-19 Clinical Research Studies
    • Viral gastroenteritis research and epidemiology
    • SARS-CoV-2 detection and testing
    • Animal Virus Infections Studies

Papers in

Amy Sims

72 papers receiving 7.3k citations

Amy Sims's Hit Papers

Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV 2020 · 1.3k citations
1.3k0+5+10Years since publication4008001.2k

Peers

Amy Sims
Comparison fields: 5 of 154
  • Infectious Diseases 5.4k
  • Animal Science and Zoology 1.4k
  • Neurology 784
  • Modeling and Simulation 225
  • Nutrition and Dietetics 399
Replace Natalya Vasilieva with:
Natalya Vasilieva United States
Anthony R. Fehr United States
Timothy P. Sheahan United States
Jian Shang China
Gang Ye China
Yushun Wan China
Rachel L. Graham United States
Swee Kee Wong United States
Matthew B. Frieman United States
Qibin Geng United States
Amy Sims relative to Natalya Vasilieva United States Natalya Vasilieva's profile →
Citations per field
00.5×3.2×
Natalya Vasilieva · 1×
Citations per year

Countries citing papers authored by Amy Sims

Since Specialization
Citations

This map shows the geographic impact of Amy Sims's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Sims with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Sims more than expected).

Fields of papers citing papers by Amy Sims

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Sims. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Sims. The network helps show where Amy Sims may publish in the future.

Co-authors

The 25 scholars most cited alongside Amy Sims, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Amy Sims Line = papers co-authored together Amy Sims links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
Hit paper breakdown →
20201274
2
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
Hit paper breakdown →
20181061
3
Zn2+ Inhibits Coronavirus and Arterivirus RNA Polymerase Activity In Vitro and Zinc Ionophores Block the Replication of These Viruses in Cell Culture
Hit paper breakdown →
2010700
4
Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase
Hit paper breakdown →
2019385
5 2016263
6
Small-Molecule Antiviral β- d - N 4 -Hydroxycytidine Inhibits a Proofreading-Intact Coronavirus with a High Genetic Barrier to Resistance
Hit paper breakdown →
2019258
7 2005258
8 2005209
9 2006208
10 2013193
11 2015190
12 2008187
13 2016170
14 2005142
15 2018133
16 2019129
17 2020117
18 2016116
19 2010107
20 2007107

About Amy Sims

Amy Sims is a scholar working on Infectious Diseases, Animal Science and Zoology, Molecular Biology, Epidemiology and Cardiology and Cardiovascular Medicine, having authored 77 papers that have together received 7.5k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (42 papers), Viral gastroenteritis research and epidemiology (36 papers), Animal Virus Infections Studies (32 papers), Viral Infections and Immunology Research (8 papers), Respiratory viral infections research (7 papers), COVID-19 Clinical Research Studies (5 papers), RNA and protein synthesis mechanisms (4 papers) and Virus-based gene therapy research (4 papers). The work is most often cited by research in Infectious Diseases (5.4k citations), Animal Science and Zoology (1.4k citations), Neurology (784 citations), Modeling and Simulation (225 citations) and Nutrition and Dietetics (399 citations). Amy Sims has collaborated with scholars based in United States, France and Netherlands. Frequent co-authors include Ralph S. Baric, Mark R. Denison, Timothy P. Sheahan, Rachel L. Graham, Boyd L. Yount, Tomáš Cihlář, Joy Y. Feng, Raymond J. Pickles, Robert Jordan and Michael O. Clarke. Their work appears in journals such as Journal of Virology, Advances in experimental medicine and biology, Proceedings of the National Academy of Sciences, mBio and The Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact